and recommendation
Biostage (BSTG)
Biostage is a biotechnology company developing bioengineered organ implants based on the Company's Cellframe™ technology which combines a proprietary biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants.
Cellspan implants are being developed to treat life-threatening conditions of the esophagus, bronchus or trachea with the hope of dramatically improving the treatment paradigm for patients.
Based on its pre-clinical data, Biostage has selected life-threatening conditions of the esophagus as the initial clinical application of its technology.
- July 21, 2016 - 9:35am | Research Notes
- June 29, 2016 - 8:59am | Research Notes
- June 24, 2016 - 12:48pm | Research Notes
- May 12, 2016 - 9:33am | Research Notes, Henry'omics, Regulatory
- March 31, 2016 - 7:43am | Henry'omics, Out and About
Pages
- « first
- ‹ previous
- 1
- 2
- 3
- 4